RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/28380378http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/28380378http://www.w3.org/2000/01/rdf-schema#comment"In cells experiencing unrelieved endoplasmic reticulum (ER) stress, the ER transmembrane kinase/endoribonuclease (RNase)-IRE1α-endonucleolytically degrades ER-localized mRNAs to promote apoptosis. Here we find that the ABL family of tyrosine kinases rheostatically enhances IRE1α's enzymatic activities, thereby potentiating ER stress-induced apoptosis. During ER stress, cytosolic ABL kinases localize to the ER membrane, where they bind, scaffold, and hyperactivate IRE1α's RNase. Imatinib-an anti-cancer tyrosine kinase inhibitor-antagonizes the ABL-IRE1α interaction, blunts IRE1α RNase hyperactivity, reduces pancreatic β cell apoptosis, and reverses type 1 diabetes (T1D) in the non-obese diabetic (NOD) mouse model. A mono-selective kinase inhibitor that allosterically attenuates IRE1α's RNase-KIRA8-also efficaciously reverses established diabetes in NOD mice by sparing β cells and preserving their physiological function. Our data support a model wherein ER-stressed β cells contribute to their own demise during T1D pathogenesis and implicate the ABL-IRE1α axis as a drug target for the treatment of an autoimmune disease."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.org/dc/terms/identifier"doi:10.1016/j.cmet.2017.03.018"xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Wang L."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Ghosh R."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Maly D.J."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Morita S."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Rosenthal W."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Papa F.R."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Bluestone J.A."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Mehdizadeh M."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Villalta S.A."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Backes B.J."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Hoffmann-Petersen I.T."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Feldman H.C."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Meza-Acevedo R."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Colon-Negron K."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/author"Register A.C."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/date"2017"xsd:gYear
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/name"Cell Metab"xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/pages"883-897.e8"xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/title"Targeting ABL-IRE1alpha Signaling Spares ER-Stressed Pancreatic beta Cells to Reverse Autoimmune Diabetes."xsd:string
http://purl.uniprot.org/citations/28380378http://purl.uniprot.org/core/volume"25"xsd:string
http://purl.uniprot.org/citations/28380378http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/28380378
http://purl.uniprot.org/citations/28380378http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/28380378